Survival analysis of patients operated by NSS compared to patients operated conventionally for renal cell carcinoma
 
More details
Hide details
1
Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
 
2
Department of Thoracic Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
 
 
Corresponding author
Julia Wątor   

Katedra i Zakład Patomorfologii, ul. 3 Maja 13-15, 41-800 Zabrze
 
 
Ann. Acad. Med. Siles. 2025;79:80-84
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Renal cell carcinoma (RCC) accounts for 2% of all cancers worldwide and causes 2% of cancer deaths. There are three types of RCC: clear cell (ccRCC), papillary (pRCC), and chromophobe (chRCC). The most common symptoms are hematuria (often periodic), pain in the lumbar region, weight loss, weakness, and periodic fever with night sweats. Often, in advanced stages, there is an abdominal tumor, enlargement of the cervical and supraclavicular lymph nodes, swelling of the lower limbs, and varicose veins.

Material and methods:
249 patients with RCC were enrolled in the study, including 203 (81.5%) with ccRCC, 32 (12.9%) with pRCC, and 14 (5.6%) with chRCC. We focused on a comparison of the surgical treatment outcomes between radical nephrectomy (RN) and nephron-sparing surgery (NSS) in terms of qualitative and quantitative characteristics.

Results:
It was estimated that factors such as the maximum tumor size, age at the day of surgery and sarcomatic transformation had the greatest impact on survival. Also, important factors are the cancer type, cancer stage, WHO grading, embolism, vascular invasion, nerve invasion, fat capsule infiltration and fibrous capsule infiltration.

Conclusions:
The results suggest that the above factors should be taken into account when choosing the appropriate treatment method as it allows the patient’s life to be extended and the number of postoperative complications to be reduced.
REFERENCES (8)
1.
Padala S.A, Kallam A. Clear Cell Renal Carcinoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Published online 2022, https://pubmed.ncbi.nlm.nih.go... [accessed on 17 February 2023].
 
2.
Capitanio U., Bensalah K., Bex A., Boorjian S.A., Bray F., Coleman J. et al. Epidemiology of renal cell carcinoma. Eur. Urol. 2019; 75(1): 74–84, doi: 10.1016/j.eururo.2018.08.036.
 
3.
Chrabańska M., Kiczmer P., Drozdzowska B. Correlation among different pathologic features of renal cell carcinoma: a retrospective analysis of 249 cases. Int. J. Clin. Exp. Pathol. 2020; 13(7): 1720–1726.
 
4.
Vander Eeckt K., Joniau S., Van Poppel H. Open surgery for localized RCC. ScientificWorldJournal 2007; 7: 742–752, doi: 10.1100/TSW.2007.142.
 
5.
Wilde J.C., Aronson D.C., Sznajder B., Van Tinteren H., Powis M., Okoye B. et al. Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience. Pediatr. Blood Cancer 2014; 61(12): 2175–2179, doi: 10.1002/pbc.25185.
 
6.
Delahunt B., Cheville J.C., Martignoni G., Humphrey P.A., Magi-Galluzzi C., McKenney J. et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am. J. Surg. Pathol. 2013; 37(10): 1490–1504, doi: 10.1097/PAS.0b013e318299f0fb.
 
7.
Moch H., Cubilla A.L., Humphrey P.A., Reuter V.E., Ulbright T.M. The 2016 WHO classification of tumours of the urinary system and male genital organs – part A: renal, penile, and testicular tumours. Eur. Urol. 2016; 70(1): 93–105, doi: 10.1016/j.eururo.2016.02.029.
 
8.
Amin M.B., Greene F.L., Edge S.B., Compton C.C., Gershenwald J.E., Brookland R.K. et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 2017; 67(2): 93–99, doi: 10.3322/caac.21388.
 
eISSN:1734-025X
Journals System - logo
Scroll to top